An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system

被引：135
|
作者：
Singleton, JA
Lloyd, JC
Mootrey, GT
Salive, ME
Chen, RT
机构：
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Vaccine Safety & Dev Author, Atlanta, GA 30333 USA
[2] US FDA, Div Biostat & Epidemiol, Rockville, MD 20857 USA
来源：
VACCINE | 1999年 / 17卷 / 22期
关键词：
vaccines; postmarketing surveillance; adverse effects;
D O I：
10.1016/S0264-410X(99)00132-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We evaluated the Vaccine Adverse Event Reporting System (VAERS), the spontaneous reporting system for vaccine-associated adverse events in the United Slates, as a public health surveillance system, using evaluation guidelines from the Centers for Disease Control and Prevention. We found that VAERS is simple for reporters to use, flexible by design and its data are available in a timely fashion. The predictive value positive for one severe event is known to be high, but for most events is unknown. The acceptability, sensitivity and representativeness of VAERS are unknown, The study of vaccine safety is complicated by underreporting, erroneous reporting, frequent multiple exposures and multiple outcomes. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2908 / 2917
页数：10
相关论文
共 50 条
  • [11] Invasive and In Situ Cervical Cancer Reported to the Vaccine Adverse Event Reporting System (VAERS)
    Wong, Charlene
    Krashin, Jamie
    Rue-Cover, Alison
    Saraiya, Mona
    Unger, Elizabeth
    Calugar, Angela
    Markowitz, Lauri
    [J]. JOURNAL OF WOMENS HEALTH, 2010, 19 (03) : 365 - 370
  • [12] THE VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS) (VOL 12, PG 542, 1994)
    CHEN, RT
    RASTOGI, SC
    MULLEN, JR
    HAYES, SW
    COCHI, SL
    DONLON, JA
    WASSILAK, SG
    [J]. VACCINE, 1994, 12 (10) : 960 - 960
  • [13] Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)
    Emily Jane Woo
    Robert Ball
    Dale R. Burwen
    M. Miles Braun
    [J]. Drug Safety, 2008, 31 : 667 - 674
  • [14] The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barre syndrome
    Miller, Elaine R.
    McNeil, Michael M.
    Moro, Pedro L.
    Duffy, Jonathan
    Su, John R.
    [J]. VACCINE, 2020, 38 (47) : 7458 - 7463
  • [15] Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
    McNeil, Michael M.
    Li, Rongxia
    Pickering, Susanne
    Real, Theresa M.
    Smith, Philip J.
    Pemberton, Michael R.
    [J]. VACCINE, 2013, 31 (24) : 2673 - 2679
  • [16] Quantitative Vaccine Safety Signal Detection Techniques Using Vaccine Adverse Event Reporting System (VAERS)
    Liang, Huifang
    Sakaguchi, Motonobu
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 238 - 238
  • [17] Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Sever, JL
    Brenner, AI
    Gale, AD
    Lyle, JM
    Moulton, LH
    Ward, BJ
    West, DJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (12) : 825 - 840
  • [18] Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Zhang, Bicheng
    Marquez, Paige
    Reich, Jonathan
    [J]. JOURNAL OF PEDIATRICS, 2023, 262
  • [19] Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics impact
    Almadani, Ohoud A.
    Alshammari, Thamir M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 610 - 611
  • [20] Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics' impact
    Almadani, Ohoud A.
    Alshammari, Thamir M.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (12) : 1725 - 1735
12345